Newborn Screening for SMA and SCID Market
Newborn Screening for SMA and SCID Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Newborn Screening for SMA and SCID Market Size and Growth
The Newborn Screening market for Spinal Muscular Atrophy (SMA) and Severe
Combined Immunodeficiency (SCID) is experiencing growth due to increased awareness and advancements in diagnostic technologies. The market size is projected to reach approximately $200 million by 2025, driven by rising screening initiatives and government support for early detection and intervention.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Perkinelmer
◍ Thermo Fisher
◍ ImmunoIVD
◍ Labsystems Diagnostics
The newborn screening market for SMA and SCID is competitive, with key players like PerkinElmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. They contribute by advancing diagnostic technologies, enhancing screening accuracy, and expanding market access. Their innovations and services drive market growth, fostering earlier disease detection and improved patient outcomes. Sales figures include:
- PerkinElmer: ~$3 billion
- Thermo Fisher: ~$25 billion
- ImmunoIVD: Not publicly disclosed
- Labsystems Diagnostics: Not publicly disclosed
Request Sample Report
Market Segmentation
By Application
SCID Screening
SMA Screening
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
